ET
GMAB icon

Entropy Technologies’s Genmab GMAB Stock Holding History

Entropy Technologies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
+48,654
New +$1.29M 0.05% 435

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Entropy Technologies's GMAB Position: Q2 2026 in Review

Entropy Technologies opened a new position in Genmab (GMAB) in Q2 2026: 48,654 shares worth $1.34M. The stake represents 0.05% of the portfolio and ranks #435 among its holdings.

289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Entropy Technologies held 48,654 shares of Genmab worth $1.34M as of Q2 2026.
  • Genmab was a new Entropy Technologies position in Q2 2026.
  • Genmab made up 0.05% of Entropy Technologies's portfolio in Q2 2026, its #435 holding.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.